Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
The LancetPublished 1 July 2002
Matthias Egger, Margaret May, Geneviève Chêne, Andrew Phillips, Bruno Ledergerber, François Dabis
Citations1,524
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The CD4 cell count at initiation was the dominant prognostic factor in patients starting HAART, and should be taken into account in future treatment guidelines.
Abstract
The CD4 cell count at initiation was the dominant prognostic factor in patients starting HAART. Our findings have important implications for clinical management and should be taken into account in future treatment guidelines.
Keywords
Immunology and MicrobiologyMedicine
IEEE Transactions on Automatic ControlA new look at the statistical model identification
50,732 Citations1974Hirotugu Akaike
ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/)Discussion on the paper by Spiegelhalter, Best, Carlin and van der Linde
12,771 Citations2002Gelfand, A. E., Trevisani, M.
Statistics in MedicineMULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS
9,798 Citations1996Frank E. Harrell, Kerry L. Lee +1 more
Clinical Infectious Diseases1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults
4,356 Citations1993K. G. Castro, Jill Ward +5 more
The classification system for HIV infection is revised to emphasize the clinical importance of the CD4+ T-lymphocyte count in the categorization of HIV-related clinical conditions and the AIDS surveillance case definition is expanded.
New England Journal of MedicineA Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
2,666 Citations1997Scott M. Hammer, Kathleen Squires +14 more
Treatment with indinavir, zidovudine, and lamivudine as compared with zidvudine and lam ivudine alone significantly slows the progression of HIV-1 disease in patients with 200 CD4 cells or fewer per cubic millimeter and prior exposure to zidavudine.
Annals of Internal MedicinePlasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection
2,085 Citations1997John W. Mellors, Alvaro Munoz +10 more
This study compared the prognostic value of plasma viral load with that of clinical, serologic, and cellular markers in a large cohort of HIV-infected men and incorporated the two most predictive markers-plasma viral load and CD4+ lymphocyte count-into a regression tree that is useful for assessing the prognosis of individual patients.
New England Journal of MedicineTreatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
1,900 Citations1997Roy M. Gulick, John W. Mellors +14 more
In most HIV-infected patients with prior antiretroviral therapy, the combination of indinavir, zidovudine, and lamivudine reduces levels of HIV RNA to less than 500 copies per milliliter for as long as one year.
The LancetChanging patterns of mortality across Europe in patients infected with HIV-1
1,284 Citations1998Amanda Mocroft, Stefano Vella +9 more
Death rates across Europe among patients infected with HIV-1 have been falling since September, 1995, and at the beginning of 1998 were less than a fifth of their previous level.
Annals of Internal MedicineAssessing the Generalizability of Prognostic Information
1,170 Citations1999Amy C. Justice, Kenneth E. Covinsky +1 more
PubMedSurveillance for dracunculiasis, 1981-1991.
1,111 Citations1992Hopkins Dr, Ernesto Ruiz‐Tiben
Methods for conducting surveillance of dracunculiasis and other important diseases must continue to be developed and improved as countries now believed to be free of dracanculiasis prepare to apply to WHO for certification of elimination.
The LancetClinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
933 Citations1999Bruno Ledergerber, Matthias Egger +10 more
The rate of virological failure of HAART was high among patients with a history of antiretroviral treatment, but the probability of clinical progression was low even in patients with viral rebound.
The LancetClinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
901 Citations2000Gilbert Greub, B Ledergerber +13 more
Hematitis C virus and active intravenous drug use could be important factors in the morbidity and mortality among HIV-1-infected patients, possibly through impaired CD4-cell recovery in HCV seropositive patients receiving potent antiretroviral therapy.
JAMAAssociation of Cancer With AIDS-Related Immunosuppression in Adults
809 Citations2001Morten Frisch
Although occurring in overall excess, most non-AIDS-defining cancers do not appear to be influenced by the advancing immunosuppression associated with HIV disease progression.
JAMARates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy
734 Citations2001Robert S. Hogg
The data demonstrate uniformly low rates of disease progression to death and AIDS or death among patients starting antiretroviral therapy with CD4 cell counts of at least 200/microL, as well as a prior diagnosis of acquired immunodeficiency syndrome (AIDS).
The LancetResponse to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
661 Citations2002Jacques Fellay, Catia Marzolini +14 more
The polymorphism MDR1 3435 C/T predicts immune recovery after initiation of antiretroviral treatment, which suggests that P-glycoprotein has an important role in admittance of antifiltration drugs to restricted compartments in vivo.
BMJImpact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
624 Citations1997Matthias Egger, Bernard Hirschel +8 more
The introduction of antiretroviral combination therapies outside the selected patient groups included in clinical trials has led to comparable reductions in disease progression and mortality in Switzerland.
AIDSInsights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients
554 Citations2000Antonella d’Arminio Monforte, Alessandro Cozzi‐Lepri +15 more
If the current HAART regimen caused no toxicity, less than 10% of naïve patients discontinue their firstHAART regimen because of failure after 1 year from starting therapy.
The LancetRandomised placebo-controlled trial of ritonavir in advanced HIV-1 disease
540 Citations1998D. William Cameron, Margo Heath‐Chiozzi +9 more
Although earlier intervention with combination therapy may provide much more effective treatment, ritonavir in patients with advanced disease and extensive previous antiretroviral use is safe and effective, lowers the risk of AIDS complications, and prolongs survival.
The LancetCommunity-based approaches to HIV treatment in resource-poor settings
518 Citations2001Paul Farmer, Fèrnet Leandre +10 more
It is shown that it is possible to carry out an HIV treatment programme in a poor community in rural Haiti, and it is suggested that directly-observed therapy of chronic infectious disease with multidrug regimens can be highly effective in settings of great privation as long as there is sustained commitment to uninterrupted care that is free to the patient.
The LancetTime from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis
453 Citations2000
Before widespread use of highly-active antiretroviral therapy (before 1996), time since seroconversion and age at serconversion were the major determinants of survival and development of AIDS in Europe, North America, and Australia.
AIDSChanging incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy
418 Citations1997HR Brodt, Bernd S. Kamps +4 more
The incidence of AIDS-defining events in patients with advanced HIV infection at Frankfurt University Hospital has declined by more than 70% from 1992 to 1996, with a trend for malignancies and single opportunistic infections, with the exception of mycobacterial diseases.
Annals of Internal MedicineClinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy
415 Citations2000Sophie Grabar, Vincent Le Moing +5 more
Clinical outcomes are reported in a large cohort of patients in France 24 months after initiation of triple therapy that contained protease inhibitors, according to virologic and immunologic response at 6 months, and the long-term prognosis of patients exhibiting such discordant responses remains unknown.
PubMedImproved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.
324 Citations1999Robert S. Hogg, Benita Yip +5 more
This population-based cohort study confirms that patients initially treated with a triple-drug antiretroviral regimen comprising 2 NRTIs plus protease inhibitor or a non-NRTI have a lower risk of morbidity and death than patients treated exclusively with 2 N RTIs.
JAMAHIV Viral Load Response to Antiretroviral Therapy According to the Baseline CD4 Cell Count and Viral Load
292 Citations2001Andrew Phillips
Lower CD4 cell counts and higher viral loads at baseline were not associated with poorer virological outcome of ART, and those with baseline viral loads of greater than 100 000 copies/mL had a slower rate of achieving viral suppression.
Statistics in MedicineThe need for randomization in the study of intended effects
278 Citations1983Olli S. Miettinen
The need for randomization as a means of controlling confounders is accentuated in the study of intended effects (efficacy) as compared with unintended ones (toxicity), because the indication for intervention is inherently a confounder in theStudy of efficacy but not of toxicity.
AIDSVirological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients
277 Citations1997Gerd Fätkenheuer, Albert Theisen +11 more
An unexpectedly high rate of virological treatment failure of protease inhibitor therapy was found in an unselected cohort of HIV-infected patients in two German tertiary care treatment centres.
The Stata Journal Promoting communications on statistics and StataFlexible Parametric Alternatives to the Cox Model, and more
259 Citations2001Patrick Royston
The Stata implementation of a class of flexible parametric survival models recently proposed by Royston and Parmar (2001) will be described and examples based on a study of prognostic factors in breast cancer are given.
Archives of Internal MedicineLimited Patient Adherence to Highly Active Antiretroviral Therapy for HIV-1 Infection in an Observational Cohort Study
253 Citations2001Pythia T. Nieuwkerk
Deviation from the antiretroviral regimen was associated with decreased drug exposure and a decreased likelihood of having suppressed plasma HIV-1 RNA loads, and patient adherence should remain a prime concern in the management of HIV- 1 infection.
The Journal of Infectious DiseasesInfluence of Age on CD4 Cell Recovery in Human Immunodeficiency Virus–Infected Patients Receiving Highly Active Antiretroviral Therapy: Evidence from the EuroSIDA Study
218 Citations2001Jean‐Paul Viard, Amanda Mocroft +9 more
Time to a CD4 increase of >200x106 cells/L was shorter for patients in the younger age groups, as confirmed by multivariate analysis (P<10-4).
AIDSImpact of opportunistic disease on survival in patients with HIV infection
187 Citations1998Richard E. Chaisson, Joel E. Gallant +2 more
Most opportunistic diseases increase the risk of death independently of CD4 cell count, and data support the hypothesis that opportunistic Diseases enhance HIV pathogenesis and further underscore the importance of prophylaxis.
AIDSImmunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study
180 Citations2001Traci E. Yamashita, John Phair +7 more
Immunologic and virologic response to HAART was stronger in individuals who had no prior experience with the antiretroviral therapy agents subsequently included in their initial HAART regimen.
AIDSPredictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor
153 Citations1998Amanda Mocroft, M. John Gill +2 more
A significant proportion of patients in a routine clinic setting achieved an undetectable viral load measurement after first starting a protease inhibitor; viral load in patients with a higher CD4 cell count was more likely to become and stay undetECTable.
AIDSSevere hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations Aquitaine Cohort, France, 1996-1998
146 Citations1999Marianne Savès, Stéphanie Vandentorren +7 more
Hepatic cytolysis is more frequent among patients treated with HAART than with two NRTIs, and co-infections with hepatitis B virus or hepatitis C virus may modify the management of HIV-infected patients treated by HAART.
JAMAImmune Restoration With Antiretroviral Therapies
142 Citations2000Michael M. Lederman, Hernan Valdez
There is insufficient information to conclude that the risks of non-Hodgkin lymphoma and other malignancies are diminishing among persons with HIV infection, although limited data suggest that treatment earlier during the course of HIV infection may result in greater preservation of immune function.
PubMedMore rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts.
142 Citations1991Andrew Phillips, C. A. Lee +6 more
Prophylaxis against opportunistic infections may be indicated at higher CD4+ T-cell counts in older people than in younger people, because of the tendency for older people with HIV infection to progress more rapidly to AIDS.
The Journal of Infectious DiseasesA Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study
129 Citations2002Jens Lundgren, Amanda Mocroft +9 more
A scoring system was derived from an inception cohort of 8457 HIV-infected persons and a single unit increase in the score was associated with a 38% increased risk of clinical progression and can be used in patient and resource management.
American Journal of Public HealthImpact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program.
126 Citations1989Peter A. Selwyn, Diana Hartel +2 more
The data suggest that the AIDS epidemic has had a profound effect on patterns of morbidity and mortality among intravenous drug users in this methadone program population, and drug treatment programs may be important sites for targeting clinical services for drug users with AIDS.
The LancetHit HIV-1 hard, but only when necessary
124 Citations2000Mark Harrington, Charles C. J. Carpenter
Randomised, controlled trial data show that combination antiretroviral therapy for HIV-1 infection benefits people with CD4-cell counts less than 350 cells/microL, and data are discussed that justify this balanced approach and the feasibility of randomised controlled trials to provide clearer answers about when to start treatment.
Journal of Clinical MicrobiologyMulticenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma
116 Citations1996Rob Schuurman, Diane Descamps +9 more
Three procedures for the quantification of human immunodeficiency virus type 1 (HIV-1) RNA from plasma were compared at three laboratories and all three assays demonstrated equal reliability, which was independent of batched or unbatched analysis of replicate samples.
The Journal of Infectious DiseasesPredictors of Long‐Term Increase in CD4<sup>+</sup>Cell Counts in Human Immunodeficiency Virus–Infected Patients Receiving a Protease Inhibitor–Containing Antiretroviral Regimen
111 Citations2002Vincent Le Moing, Rodolphe Thiébaut +8 more
If CD4(+) cell counts can remain elevated despite virologic treatment failure, such a discrepant response may be transient in patients who have a high plasma HIV RNA level at the time of treatment failure.
AIDS Research and Human RetrovirusesHuman Immunodeficiency Virus Type 1 RNA Level and CD4 Count as Prognostic Markers and Surrogate End Points: A Meta-Analysis
90 Citations2000
Change in HIV-1 RNA, particularly using AUCMB, and in CD4 count should be measured to aid patient management and evaluation of treatment activity in clinical trials because two randomized treatment comparisons may show similar differences between treatments in marker changes but not similar differences in progression to AIDS/death.
AIDSCD4 cell count as a surrogate endpoint in HIV clinical trials
75 Citations1998Michael D. Hughes, Michael J. Daniels +3 more
CD4 cell count is a weak surrogate endpoint, but has some value as an aid for screening treatments for drug development or preliminary regulatory approval, and other mechanisms of drug action not captured by initial change in CD4 cells are important.
JAIDS Journal of Acquired Immune Deficiency SyndromesGender Differences in Virologic Response to Treatment in an HIV-Positive Population: A Cohort Study
73 Citations2001Antonia L. Moore, Amanda Mocroft +5 more
Women may achieve virologic suppression at a faster rate than men and have a more durable response to highly active antiretroviral treatment, according to a cohort of HIV‐positive individuals.
International Journal of EpidemiologyDifferences in Mortality Rates and Causes of Death between HIV Positive and HIV Negative Intravenous Drug Users
68 Citations1993Anne Eskild, Per Magnus +3 more
Drug overdose represented the major threat to life among IVDU in this study and may have an increasing impact on mortality because of the dynamics of the HIV epidemic.
Journal of Acquired Immune Deficiency Syndromes & Human RetrovirologyRegional Differences in Use of Antiretroviral Agents and Primary Prophylaxis in 3122 European HIV-Infected Patients
65 Citations1997Jens Lundgren, Andrew Phillips +11 more
ARV therapy was more frequently used among patients from southern and central Europe as compared with patients from northern Europe, especially among patients with CD4 counts >200 cells/microl, and antifungal therapies are used differently in different parts of Europe.
American Journal of EpidemiologyModeling Changes in CD4-positive T-Lymphocyte Counts after the Start of Highly Active Antiretroviral Therapy and the Relation with Risk of Opportunistic Infections The Aquitaine Cohort, 1996–1997
51 Citations2001Christine Binquet, Geneviève Chêne +5 more
The results indirectly reinforce the concept of a delayed but possible immune recovery with the use of protease inhibitors and support the potential for interruption of certain types of prophylaxis against opportunistic infections under reasonable conditions of duration of antiretroviral therapy and sustained CD4+ cell response.
AIDSThe changing pattern of admissions to a London hospital of patients with HIV: 1988-1997
51 Citations1999Amanda Mocroft, Simon Barry +8 more
Admissions to hospital began falling before the introduction of combination therapy and declined strikingly during 1996 and 1997 following the introductionof highly active antiretroviral therapy.
JAIDS Journal of Acquired Immune Deficiency SyndromesGender Differences in Virologic Response to Treatment in an HIV-Positive Population: A Cohort Study
44 Citations2001Antonia L. Moore, Amanda Mocroft +5 more
AIDSHighly active antiretroviral therapy and coronary heart disease: the need for perspective
30 Citations2001Matthias Egger, Cornelia Junghans +2 more
Using data from prospective studies of HIV-1 infection, a brief overview of cardiovascular epidemiology with an emphasis on coronary heart disease (CHD) is presented and the metabolic complications associated with the lipodystrophy syndrome are reviewed.
JAIDS Journal of Acquired Immune Deficiency SyndromesZidovudine and Stavudine Sequencing in HIV Treatment Planning: Findings From the CHORUS HIV Cohort
28 Citations2001Stephen Becker, Stephen R. Raffanti +6 more
Prior zidovudine therapy was not associated with long-term attenuation of HIV-I RNA or CD4 response to subsequent stavudine-containing regimens and may have benefit in a strategic long- term therapeutic plan.